Axogen, Inc. shares have seen a notable increase following a positive forecast from investment analysts at Leerink Partners. On November 25, Leerink Partners raised their earnings per share (EPS) estimates for Axogen for the fiscal year 2024, now expecting a slightly improved EPS of ($0.31) compared to their previous estimate of ($0.32). This adjustment reflects a more optimistic outlook on the company's financial performance. Additionally, the consensus estimate for Axogen's full-year earnings stands at ($0.30) per share, indicating a general positive sentiment among analysts.
Axogen's stock is currently trading at $15.00, marking a 10.21% increase from its previous close of $13.61.